glp 1 receptor agonist structure of [ 3 H]liraglutide (top) and the GLP-1 agonists Chemical structures of GLP-1 receptor

Based on their test results and an initial consultation, a doctor may prescribe patients to start off with a low dosage of GLP-1s that is slowly ramped up over time to meet the desired dosage amount

Besides obesity management, there have been efforts by various drugmakers for the clinical use of GLP-1 medications for cardiovascular conditions, chronic kidney disease, obstructive sleep apnea, and neurodegenerative diseases

On August 8th, the company had a press release to announce that the primary endpointcardiovascular death, heart attack or strokewas reduced by 20%

Prevalence of obesity and severe obesity among adults: United States, 2017-2018

Nevertheless, these findings point to complex interaction between GLP-1 and the gut, brain, immune system, and gut microbiota in control of inflammation (Figure 3 and Figure 4), offering osteoarthritis as a relevant inflammation model to explore the systemic, integrative actions of GLP-1 medicines beyond metabolic control (Figure 4)